Art. 17 Regulation (EU) 2024/1381

Re-initiation of joint clinical assessments

In forcesince 23 May 2024
1.

Where the joint clinical assessment has been discontinued pursuant to Article 10(6) of Regulation (EU) 2021/2282, and where, at least 30 days before the end of the deadline referred to in Article 10(7) thereof, the Member State shares through the HTA IT platform the information, data, analyses and other evidence that formed part of the Commission’s first request, the Commission shall confirm whether, based on the information available at the time, the requirements laid down in Articles 9(2), (3) and (4) of Regulation (EU) 2021/2282 have been met.

2.

The Commission shall provide the confirmation referred to in paragraph 1 within 10 working days from the date on which the Member State shared these data and as appropriate in consultation with the assessor and co-assessor. The HTA secretariat shall inform the Coordination Group and the health technology developer of the results of the Commission’s assessment.

3.

Where the Coordination Group decides to re-initiate a joint clinical assessment pursuant to Article 10(7) of Regulation (EU) 2021/2282, Article 14 and Article 15(1), (3) and (5) of this Regulation shall apply.

4.

The HTA secretariat shall inform the health technology developer of the re-initiation of a joint clinical assessment.